Table 2 Transplant Characteristics
Variable | AT2S (n=20) | Adrenergic Vasopressors (n=60) | p-value |
|---|---|---|---|
Deceased donor transplant, n (%) | 14 (70) | 32 (54.2) | 0.217 |
Donor terminal SCr, mg/dL | 1.79 (1.7) | 1.11 (0.86) | 0.027 |
Kidney donor profile index, % | 48.9 (27.8) | 52 (26.7) | 0.727 |
Donor age, years | 45.4 (11.9) | 41.2 (12.4) | 0.199 |
Cold ischemic time, hours | 14.7 (8.6) | 7.9 (5.6) | < 0.001 |
Duration of surgery, hours | 5.19 (1.9) | 4.31 (2) | 0.087 |
Thymoglobulin induction, n (%) | 13 (65) | 37 (61.7) | 0.8 |
Basiliximab induction, n (%) | 7 (35) | 17 (28.3) | 0.233 |
Tacrolimus maintenance immunosuppression, n (%) | 20 (100) | 56 (93.3) | 0.567 |
Mycophenolate maintenance immunosuppression, n (%) | 15 (75) | 57 (95) | 0.021 |
Intraoperative estimated blood loss, mL | 278.3 (383.5) | 189.3 (140) | 0.196 |
Intraoperative continuous infusion propofol, n (%) | 11 (55) | 19 (31.7) | 0.062 |
Intravenous push propofol, n (%) | 20 (100) | 58 (96.7) | 0.408 |
-Dose of propofol, mg | 133.8 (61.9) | 131.2 (53.7) | 0.858 |